Supported by: Madrigal
Organized by: Medscape Education
Presenters:
Manal F. Abdelmalek, MD
Stephen A. Harrison, MD
Mary E. Rinella, MD
The incidence of nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction-associated steatohepat
Mayo Clinic
Asan Medical Center, University of Ulsan College of Medicine
Mayo Clinic
Montefiore Medical Center
Montefiore Medical Center
Seoul National University
New York-Presbyterian Hospital-Columbia
Massachusetts General Hospital
Supported by: AstraZeneca
This promotional program covers the HIMALAYA trial of the IMFINZI + IMJUDO immunotherapy regimen in patients with unresectable HCC. The presentation has been updated with results from the HIMALAYA 4-year exploratory analysis sho